| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 02/07/2007 | CN1908012A Cell surface molecule mediating cell adhesion and signal transmission |
| 02/06/2007 | US7173107 Glycopeptide and preparation thereof |
| 02/06/2007 | US7173003 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 02/01/2007 | US20070026485 Glycopegylation methods and proteins/peptides produced by the methods |
| 01/30/2007 | US7169919 Genetically engineered lipids for use in the treatment baterial infection |
| 01/30/2007 | US7169890 New amide derivatives of deacylated ramoplanin have the same or better antinfective activity, lower hemolytic effect and better tolerability profile than ramoplanin |
| 01/25/2007 | WO2007010995A1 Method of stabilizing peptide contained in biosample |
| 01/25/2007 | US20070021328 Chloro-biphenyl-rearranged norvacomycin with improved antibacterial activity and less potential for developing resistance |
| 01/25/2007 | US20070021327 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor |
| 01/25/2007 | CA2614592A1 Method for stabilization of peptides in a biological sample |
| 01/23/2007 | CA2141106C Glycopeptide antibiotic derivatives |
| 01/18/2007 | US20070015905 2'- and 3'-prodrugs of 1', 2', 3' or 4'-branched beta -D or beta -L nucleosides, or their salts for treating hepatitis C virus infection; 3' or 4' O- substitution in furan ring containing at least one acyl or amino acid residue |
| 01/11/2007 | WO2006086012A3 Antibiotic compound |
| 01/09/2007 | US7160984 Process for preparing glycopeptide derivatives |
| 01/09/2007 | US7160856 Such as alpha-O-linked glycopeptides with clustered glycodomains which are useful as anticancer agents |
| 01/04/2007 | WO2007001335A2 Ramoplanin derivatives possessing antibacterial activity |
| 01/03/2007 | EP1539804B1 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
| 01/02/2007 | US7157554 Forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent containing a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide |
| 01/02/2007 | US7157277 Factor VIII remodeling and glycoconjugation of Factor VIII |
| 01/02/2007 | CA2134348C Polysaccharide derivatives and drug carriers |
| 12/27/2006 | EP1735337A1 Method of producing highly pure teicoplanin |
| 12/27/2006 | EP0817797B1 Glycopeptide antibiotic derivatives |
| 12/26/2006 | US7153825 Administering an exendin modified with a polyethylene glycol, gelatin and/or albumin to increase its biological half-life; treating hyperglucagonemia and diabetes, especially type II diabetes |
| 12/21/2006 | US20060287432 Peptide purification by means of metal ion affinity chromatography |
| 12/21/2006 | US20060287223 Remodeling and glycoconjugation of peptides |
| 12/14/2006 | US20060281897 Potentialization of the activation of high molecular weight prodrugs |
| 12/13/2006 | EP1729790A1 Amphipathic glycopeptides |
| 12/13/2006 | EP1617860A4 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 12/13/2006 | CN1878789A Human cathelicidin antimicrobial peptides |
| 12/07/2006 | US20060276623 Scaffolds; resistant enterococci |
| 12/07/2006 | US20060276621 Glycosylated specificity exchangers |
| 11/30/2006 | WO2006086012A8 Antibiotic compound |
| 11/30/2006 | US20060270830 Polysialic acid having a moiety linked at one or each terminal unit of a functional group of from N-maleimido, vinysulphone, N-iodoacetamide, and orthopyridyl disulphide; conjugation with protein or peptide having a cysteine to attach to the thiol;bioavailability; drug delivery |
| 11/30/2006 | US20060270624 Gapped 2' modified oligonucleotides |
| 11/29/2006 | EP1725577A1 Antithrombotic compound |
| 11/29/2006 | EP1725250A2 Method for the preparation of peptide-oligonucleotide conjugates |
| 11/29/2006 | EP0556292B2 Hepatitis c virus asialoglycoproteins |
| 11/29/2006 | CN1871253A Hydrochloride salts of a glycopeptide phosphonate derivative |
| 11/23/2006 | US20060264607 Process for preparing glycopeptide phosphonate derivatives |
| 11/23/2006 | US20060263303 Compounds for Targeting Endothelial Cells, Compositions Containing the Same and Methods for Their Use |
| 11/23/2006 | US20060263294 Tumor targeting agents and uses thereof |
| 11/22/2006 | EP1724287A1 Hyaluronic acid/methotrexate compound |
| 11/22/2006 | CN1867589A Synthetic polysaccharide antigens for immunological intervention in disease |
| 11/21/2006 | US7138489 Method for producing a modified peptide |
| 11/21/2006 | US7138487 Contacting an aqueous solution of the lipopeptide antibiotic and a divalent metal ion with an organic solvent, thereby extracting the lipopeptide antibiotic into the organic solvent; andcontacting the organic solvent extract of the lipopeptide antibiotic with acid |
| 11/21/2006 | US7138376 Composition for treating a host infected with a hepatitis C viral comprising administering an effective hepatitis C treatment amount of a described 4'-disubstituted nucleoside or a pharmaceutically acceptable salt or prodrug thereof |
| 11/21/2006 | US7138371 Remodeling and glycoconjugation of peptides |
| 11/15/2006 | EP1390521A4 Glycopeptide antibiotics |
| 11/15/2006 | CN1861629A Process for pretreating vancomycin ferment fluid for HPLC analysis |
| 11/09/2006 | US20060252051 Method for producing diverse libraries of encoded polymers |
| 11/08/2006 | CN1858061A Vacomycin column chromatography purifying method |
| 11/02/2006 | WO2006059227B1 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosurgery |
| 11/02/2006 | US20060247155 Methods for alleviating deleterious effects of 3-deoxyglucosone |
| 10/31/2006 | US7129333 Glycoprotein synthesis |
| 10/26/2006 | US20060241025 Biodegradable glucosamine-muramyl peptides for apoptosis modulation |
| 10/26/2006 | US20060241024 Intermediate for preparing glycopeptide derivatives |
| 10/25/2006 | EP1713439A1 Pharmaceutical preparation for the oral cavity |
| 10/25/2006 | CN1281619C Process for preparing glycopeptide derivatives |
| 10/24/2006 | US7125843 Glycoconjugates including more than one peptide |
| 10/19/2006 | WO2006078277A3 Dalbavancin compositions for treatment of bacterial infections |
| 10/12/2006 | US20060229235 Target-binding motif linked to a 3 beta-cholesterylamine derivative membrane-binding element by a beta-alanine subunit; for delivering a protein, peptide, drug, prodrug, lipid, nucleic acid, carbohydrate or small molecule into a target cell via receptor-mediated endocytosis |
| 10/10/2006 | US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA |
| 10/03/2006 | US7115562 Peptides and their use to ameliorate cell death |
| 09/28/2006 | US20060217319 Method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 09/28/2006 | US20060217293 Coupling low-molecular substances to a modified polysaccharide |
| 09/27/2006 | EP1705187A1 Cosmetic compositions comprising KAP-polypeptides for care, strengthening, and/or repair of substrates consisting of keratin |
| 09/26/2006 | US7112654 Ligand for vascular endothelial growth factor receptor |
| 09/26/2006 | US7112564 Biodegradable glucosaminemuramyl peptides for apoptosis modulation |
| 09/21/2006 | US20060211603 Ramoplanin derivatives possessing antibacterial activity |
| 09/20/2006 | EP1701975A1 Nonnatural c-linked carbo-beta-peptides with robust secondary structures |
| 09/20/2006 | EP1276491B1 Tamandarin and didemnin analogs and methods of making and using them |
| 09/20/2006 | EP0929569B1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 09/19/2006 | US7109323 lyophilization of an aqueous mixture comprising a boronic add compound and a compound having at least two hydroxyl groups produces a stable composition that readily releases the boronic acid compound upon dissolution in aqueous media |
| 09/19/2006 | US7109309 Peptide fructose and protein conjugate with the same |
| 09/19/2006 | US7109165 Anticarcinogenic agent is conjugated with a nucleic acids, for cancer treatment; a kit for detection; chemical intermediates |
| 09/14/2006 | WO2006061101A3 Drug delivery peptides for crossing blood-brain barrier |
| 09/13/2006 | EP1302477B1 Peptide fructose and complex thereof with binding protein |
| 09/13/2006 | CN1831007A Sythesis of sugar substituted MAVgn, 99Tcm and 186Re tag and application of said tag |
| 09/13/2006 | CN1831006A Sugar substituted MAAGn synthesis, 99Tcm or 186Rc tag and tag in application of radiation medicine for treating tumor |
| 09/13/2006 | CN1831005A Synthesis of sugar substituted MAGn, and 99Tcm or 186 Re tag and tag, application for tumor medicine thereof |
| 09/08/2006 | WO2006092313A1 Lipopeptides having pharmaceutical activity |
| 09/08/2006 | WO2005076744A3 Method for the preparation of peptide-oligonucleotide conjugates |
| 09/07/2006 | US20060199207 Self-assembly of molecules using combinatorial hybridization |
| 09/07/2006 | US20060198786 Glycopeptide compositions |
| 09/06/2006 | EP1698638A1 Lipopeptides having pharmaceutical activity |
| 09/06/2006 | CN1829742A Aminated complex-type sugar chain derivatives and process for the production thereof |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/05/2006 | US7101964 Vancomycin derivatives provide enhanced antibacterial activity, selectivity and reduced mammalian toxicity |
| 08/31/2006 | US20060194717 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 08/31/2006 | US20060194716 Polyacid glycopeptide derivatives |
| 08/31/2006 | US20060194715 Proteins encoded by ble genes and antibiotics from the bleomycin family |
| 08/31/2006 | US20060194247 Complex of antigen, antibody or ligand, receptor; therapy or prevent human disease |
| 08/30/2006 | EP1695979A2 Gapped 2' modified oligonucleotides |
| 08/24/2006 | US20060189517 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/24/2006 | US20060188916 Joining spacer to biopolymers; generate spacer, join to bioplymer, recover biopolymer; conjugation that can be carried out entirely in the solid phase, with minimal disruption to automated synthetic protocols |
| 08/23/2006 | EP1292612B1 Glycopeptide phosphonate derivatives |
| 08/23/2006 | EP1007541B1 Randomly generated glycopeptide combinatorial libraries |
| 08/22/2006 | US7094580 Methods for producing pure perlecan and other heparan sulfate proteoglycans |
| 08/17/2006 | CA2580882A1 Antibiotic compound |
| 08/15/2006 | US7090828 Vitronectin receptor antagonist pharmaceuticals |